Sentences with phrase «of immunotherapies»
The Cancer Research Institute (CRI), a nonprofit organization dedicated since 1953 to fueling the discovery and development of immunotherapies for all forms of cancer, is hosting its fourth annual Cancer Immunotherapy Month ™ in June.
http://cancerresearch.org/
Go to our Clinical Trial Finder to find clinical trials of immunotherapies for breast cancer that are currently enrolling patients.
The company uses a unique platform to identify rational combinations of immunotherapies and novel targets.
Next year, he said, the agency could approve a series of immunotherapies for ovarian cancer, non-Hodgkin's lymphoma, head and neck cancer, stomach cancer, mesothelioma and a type of breast cancer, among others.
«Combining it with Turnstone's oncolytic viral immunotherapy could be a way for more people to benefit from this emerging class of immunotherapies.
Recent evidence suggests that one major roadblock for the effective use of immunotherapies in pancreatic cancer patients is that the tumors are effectively hidden, preventing the immune system from recognizing and killing them.
The goal is to test if targeting the vitamin D receptor will unlock the potential of immunotherapies to kill pancreatic cancer tumor cells and potentially establish a therapeutic combination for controlling advanced pancreatic cancer, extending patient survival, and reducing patient side effects.
It's called atezolizumab (also known as MPDL3280A, made by Roche / Genentech) and belongs to a class of immunotherapies called checkpoint inhibitors.
A range of immunotherapies are currently in use, yet their efficacy can be varied and differ from patient to patient.
This functional characterization has provided critical translational insights that underpinned development of immunotherapies for cancer, autoimmune diseases, and transplant rejection.
Go to our Clinical Trial Finder to find clinical trials of immunotherapies for pancreatic cancer that are currently enrolling patients.
In addition to bevacizumab (Avastin ®) a targeted antibody that is already approved for cervical cancer patients, there are several other types of immunotherapies that are being evaluated for cervical cancer, including some in combination.
Go to our Clinical Trial Finder to find clinical trials of immunotherapies for lymphoma that are currently enrolling patients.
Go to our Clinical Trial Finder to find clinical trials of immunotherapies for leukemia that are currently enrolling patients.
Since that post, there have been exciting developments in the progress of the two most advanced of these immunotherapies: PD01A, the AS - targeting active vaccine from Austrian biotechnology startup AFFiRiS AG, developed using its patented «AFFITOME» neo-antigen discovery platform of molecular mimicry; and PRX002, a humanized monoclonal Ab (mAb) under development from Prothena Corp PLC, the successor of aggregate - clearing immunotherapy pioneer Élan Pharmaceuticals.
In the ensuing months, the two companies have published detailed, promising animal studies of their immunotherapies, including preclinical efficacy studies in animal models of human synucleinopathies.
The first generation of immunotherapies, including immune checkpoint inhibitors and cancer vaccines, have been limited by the proportion of patients who benefit, and by the depth and duration of response in those that do.
We are leaders in the development and advancement of immunotherapies, targeted therapies and personalised medicine.
Along with the development of investigator initiated clinical trial concepts, the application of immunotherapies and cancer vaccines to clinical trials.
The «TGF beta» clinical trial, named for one of the elements that distinguish this approach, is part of an emerging class of immunotherapies that employ adoptive cell transfer.
Opdivo, made by Bristol - Myers Squibb (BMS), belongs to a class of immunotherapies called checkpoint inhibitors.
The other major class of immunotherapies are known as anti-CTLA-4 treatments, such as ipilimumab (Yervoy), which target a different mechanism to unleash immune cells to fight tumors.
NEW YORK, August 29, 2016 — The Cancer Research Institute (CRI), a nonprofit organization dedicated to fueling the discovery and development of immunotherapies for all forms of cancer, announced today that it will honor biotechnology company Amgen with the 2016 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research at its September gala in New York City.
Go to our Cancer Immunotherapy Clinical Trial Finder to find clinical trials of immunotherapies for ovarian cancer that are currently enrolling patients.
«As we identify which bacteria have a similar effect in humans, it should be possible to develop probiotic supplements that specifically improve efficacy of immunotherapies,» he says.
«This could be a universal mechanism for enhancing efficacy of immunotherapies in glioma,» she says.
This research has important implications for the use of DNA - encoded monoclonal antibody technology as a platform for delivering the next generation of immunotherapies for cancer and many human diseases.
Carretero and his colleagues therefore investigated whether the outcomes of these immunotherapies might be improved by adding eosinophils.
Dr. Gnjatic's research focuses on human antigen - specific immune responses to tumor antigens, in an attempt to define new targets for the development of cancer immunotherapies, assess the efficacy of these immunotherapies, and learn why they may fail.
Partnering with the U.S. Food and Drug Administration allowed Doebele and colleagues to access clinical trial data describing initial tumor response, PFS and OS for 305 patients with stage IIIb or IV non-small cell lung cancer on trials of ALK inhibitors and 355 similar patients on trials of immunotherapies directed at PD - 1.
Historically, the development of vitiligo in melanoma patients has been rare, but the recent use of immunotherapies, especially checkpoint inhibitors, has increased its incidence.
The mouse model could also contribute to the further development of immunotherapies — a method in which the body's immune system is stimulated, so that it intensifies its fight against tumor cells.
With the soaring costs of some new drug treatments do you worry that most of these immunotherapies will be beyond the financial reach of all but the very rich?
The researchers then induced melanoma tumors in their model and evaluated the effects of a battery of immunotherapies.
These types of drugs could potentially be used with other sorts of immunotherapies, which are all the rage in biopharma these days.
He had been following the emerging science of immunotherapy, which is the use and augmentation of the human immune system to fight disease.
The goal of immunotherapy, researchers like Stanton say, is to target precancerous lesions or, of course, to prevent the disease altogether.
Led by Nina Bhardwaj, M.D., director of immunotherapy, the Personalized Genomic Vaccine trial uses the genetic sequence of a patient's tumor to create a customized vaccine.
CAR - T cell therapy is a form of immunotherapy, a rapidly developing cancer treatment that uses patients» own immune cells to attack tumors.
The Kamens claim the main thing that distinguishes their foundation from other brain tumor foundations is their focus on pediatric brain cancer specifically, as well as their close ties with pharmaceutical and biotech companies working in the fields of immunotherapy and target gene therapy.
To further advance the study of immunotherapy for glioblastoma, the Parker Institute for Cancer Immunotherapy is organizing a workshop starting July 27 in Los Angeles.
Another attractive aspect of immunotherapy is that it is more targeted than chemotherapy.
More human lives can be saved as a result of immunotherapy.
With that in mind, I think some of the immunotherapy stocks are valued lower than they should be.
To achieve this goal, the cancer field is moving away from chemotherapy and towards a combination of immunotherapy and targeted therapy, an approach that is more potent and less toxic.
A group of the nation's leading cancer research scientists and their Cuban counterparts are exploring how to advance cancer therapy, diagnosis, and prevention, including the use of immunotherapy to harness the body's immune systems to attack and eliminate cancer cells.
«Gradual release of immunotherapy at site of tumor surgery prevents tumors from returning.»
At Mayo, some immunologists work on basic research and others lean more toward the clinical applications of immunotherapy.
The April issue of Scientific American highlights these emerging therapies, but we have covered the growing promise of immunotherapy for quite a while.
«There are certainly challenges to overcome for clinical application of this kind of immunotherapy, but the newly published data are an important milestone in immunotherapy targeting solid tumors that have eluded other treatments.»